Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Abbott Laboratories stock outperforms competitors on strong trading day
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with unparalleled accuracy. Back To Top
Abbott Stock Trades at a Discounted P/B Value: To Buy or Not to Buy?
Abbott Laboratories ABT shares are trading at a discount to the Zacks Medical Products industry. Its trailing 12-month price-to-book value of 4.91X is significantly lower than the industry average of 7.
What’s Causing Abbott Laboratories (ABT) Stock’s 9.43% Jump Over the Last Six Months?
Abbott Laboratories (ABT) stock saw a modest uptick, ending the day at $113.83 which represents a slight increase of $0.39 or 0.34% from the prior close of $113.44. The stock opened at $113.94 and touched a low of $113.
Abbott Laboratories stock underperforms Tuesday when compared to competitors despite daily gains
Abbott Laboratories closed $8.24 below its 52-week high ($121.64), which the company achieved on March 8th.
Is Abbott Laboratories (NYSE:ABT) the Best January Dividend Stock to Buy?
We recently compiled a list of the 10 Best January Dividend Stocks To Buy. In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against the other January dividend stocks.
17h
Abbott Laboratories Q4 2024 Earnings Preview
Abbott Laboratories will report earnings pre-market on January 22, with an earnings consensus of $1.04 per share. See why I ...
6h
Abbott price target lowered to $135 from $138 at Bernstein
Bernstein analyst Lee Hambright lowered the firm’s price target on Abbott (ABT) to $135 from $138 and keeps an Outperform rating on the shares ...
Crain's Chicago Business
20h
Why Abbott and Dexcom buried the hatchet in their glucose monitor patent fight
North Chicago-based Abbott announced last month it reached a settlement agreement with Dexcom over all outstanding patent disputes relating to their glucose monitoring products, which estimate blood ...
17h
Insiders At Abbott Laboratories Sold US$3.0m In Stock, Alluding To Potential Weakness
Over the past year, many Abbott Laboratories ( NYSE:ABT ) insiders sold a significant stake in the company which ...
18h
Bernstein Sticks to Its Buy Rating for Abbott Laboratories (ABT)
In a report released yesterday, Lee Hambright from Bernstein maintained a Buy rating on Abbott Laboratories (ABT – Research Report), with a ...
Insider Monkey on MSN
11d
Why Is Abbott Laboratories (ABT) Among Diamond Hill Capital’s Top Stock Picks?
We recently compiled a list of the Diamond Hill Capital’s Top 10 Stock Picks. In this article, we are going to take a look at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback